Required sample sizes in clinical trials for lung cancer treatment results that the survival-time patterns of patients have lognormality
-
- Yamashita Nobuo
- Department of Radiology, the Kanto Teishin Hospital
Bibliographic Information
- Other Title
-
- 生存期間のパターンが対数正規性を示すと思われる肺癌のCIinical Trialに必要な症例数の検討
Search this article
Abstract
In this paper the author tried to calculate sample sizes for clinical trials in lung cancer treatment results that the survival-time patterns of patients have lognormality using the Owen's noncentral t-distribution and given following tables.<BR>The table la and lb are given the relation between the expected difference Δμ in logmean and the required sample sizes that should be included in each group of a clinical trial in lung cancer treatment results in oder to have a 90% (β=0.90), 70% (β=0.70) and 50% (β=0.50) probability detecting significant difference (!α=0.05, α=0.01) in results and covered any value of the difference ranging from 0.03 to 0.30 and any value of ranging from 0.30 to 0.50.
Journal
-
- Haigan
-
Haigan 14 (2), 79-82, 1974
The Japan Lung Cancer Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679659026432
-
- NII Article ID
- 110003125904
-
- NII Book ID
- AN00203978
-
- ISSN
- 13489992
- 03869628
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed